Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01776060 · ClinicalTrials.gov registry record
Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 28
- Enrollment target
NCT01776060 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 28 participants.
The verdict
NCT01776060 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The goal of this study is to enroll 100 participants with Primary Progressive Multiple Sclerosis (PPMS) that have joined the MURDOCK Study Horizon 1.5 (Duke IRB Pro00011196) and the Multiple Sclerosis cohort (Duke IRB Pro00023791). All 100 participants will complete a biannual collection of a follow up questionnaire and blood/urine collection for a period of 5 years.
Interventions
- OTHER generation of 'omic markers of disease progression
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2013-01 |
| Est. Completion | 2020-09-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01776060
The ClinicalTrials.gov registry entry for NCT01776060 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which generation of 'omic markers of disease progression is the first listed.
NCT01776060 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01776060 about?
NCT01776060 is a clinical study titled "Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study". The goal of this study is to enroll 100 participants with Primary Progressive Multiple Sclerosis (PPMS) that have joined the MURDOCK Study Horizon 1.5 (Duke IRB Pro00011196) and the Multiple Sclerosis cohort (Duke IRB Pro00023791). All 100 participants will complete a biannual collection of a follow...
What is the current status of trial NCT01776060?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2013-01. Estimated completion is 2020-09-21.
What interventions are being tested in trial NCT01776060?
The interventions under investigation include: generation of 'omic markers of disease progression (OTHER).
Who is sponsoring clinical trial NCT01776060?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.